Press Releases October 8, 2026 08:00 AM

Enovis to Host Third Quarter 2026 Results Conference Call on November 5th

Enovis Announces Q3 2026 Earnings Call Scheduled for November 5th

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
ENOV

Enovis Corporation, a medical technology company, will host a conference call and webcast on November 5, 2026 to discuss its Q3 financial results. An earnings press release will be issued earlier that day, and investors can access the webcast through the company's website.

Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
ENOV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Enovis is set to release its Q3 2026 financial results on November 5th, 2026.
  • The company will host an investor conference call and live webcast at 8:30 a.m. Eastern Time that day.
  • The webcast and related materials will be accessible on Enovis's investor relations website.

Dallas, TX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2026 financial results on Thursday, November 5th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com.

Conference Call/Webcast Information

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.

About Enovis
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com.

Availability of Information on the Enovis Website

Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.

Kyle Rose
Vice President, Investor Relations
Enovis Corporation
[email protected]


Risks

  • No financial guidance or preview of results was provided in this announcement, creating uncertainty around the upcoming earnings performance.
  • Market reaction will depend on the actual Q3 results and whether they meet or miss investor expectations.
  • Broader healthcare sector risks, including regulatory and reimbursement challenges, may impact Enovis's business and stock performance.

More from Press Releases

CNH Names Paul Dick, President, North America Nov 20, 2026 Harmony Biosciences to Participate in Upcoming Investor Conferences Nov 19, 2026 Pure Cycle Announces Record Financial Results For the Year Ended August 31, 2026 Nov 18, 2026 Sachem Capital Reports Third Quarter 2026 Results Nov 16, 2026 Inter&Co Delivers Record 3Q26 Net Income of US$76.1 Million, With Strong Growth, Higher Margin and Better Efficiency Nov 12, 2026